文献速递肾移植慢性肾脏病遗传性与小管间质肾病

肾移植术后骨密度丢失:代谢决定因素、诊断方法与预防策略

Bone Mineral Density Loss After Kidney Transplantation: Metabolic Determinants, Diagnostic Approaches, and Preventive Strategies.
PubMed 文献 · Kidney Int Rep · 2026-06-30

本叙述性综述总结肾移植术后第一年骨密度快速下降的幅度与时间进程,涉及免疫抑制治疗、代谢因素及移植前慢性肾脏病-矿物质骨病(CKD-MBD)的复杂交互。综述还回顾DXA、QCT、HR-pQCT、有限元分析及生化标志物等诊断策略与防治方法,指出皮质骨早期恶化、持续性甲状旁腺功能亢进及DXA单独预测价值有限,提出整合先进影像与骨转换标志物可改善风险分层。

要点

  • 肾移植术后第一年骨密度快速下降,与免疫抑制、代谢因素及移植前CKD-MBD相关。
  • 皮质骨结构早期恶化且持续性甲状旁腺功能亢进常见,DXA单独预测骨折价值有限。
  • 整合HR-pQCT等先进影像与骨转换/矿物质代谢标志物或可改善风险分层。

核心结论

  • 肾移植术后第一年骨密度快速下降反映免疫抑制治疗、代谢因素与移植前CKD-MBD的复杂交互。
  • 皮质骨结构早期恶化、持续性甲状旁腺功能亢进及DXA单独预测价值有限是当前认识重点。
  • 整合先进影像与骨转换及矿物质代谢标志物可能改善风险分层,人工智能建模与HR-pQCT表型分析有望支持个体化预防。

研究设计与样本

  • 叙述性综述,总结肾移植术后骨密度丢失的幅度、时间进程、代谢与药理机制及骨折风险。

主要发现

  • 肾移植术后第一年骨密度快速下降。
  • 近期数据提示皮质骨结构早期恶化。
  • 持续性甲状旁腺功能亢进常见。
  • DXA单独预测价值有限。

临床怎么用

  • 关注肾移植受者术后早期骨密度下降及皮质骨结构恶化。
  • 可考虑整合先进影像(如HR-pQCT)与骨转换及矿物质代谢标志物进行风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mineral and bone disease (MBD) is a frequent complication after solid organ transplantation. The rapid decline in bone mineral density (BMD) during the first year after kidney transplantation reflects complex interactions between immunosuppressive therapy, metabolic factors and pre-existing chronic kidney disease (CKD)-MBD. This narrative review summarizes the magnitude and time course of BMD loss after kidney transplantation, the underlying metabolic and pharmacologic mechanisms, and associated fracture risk. Diagnostic strategies including dual-energy X-ray absorptiometry (DXA), quantitative computed tomography (QCT), high-resolution peripheral QCT(HR-pQCT), finite element analysis (FEA), and biochemical markers are reviewed alongside preventive and therapeutic approaches. Recent data highlight early deterioration of cortical bone structure, persistent hyperparathyroidism, and the limited predictive value of DXA alone. Integration of advanced imaging and bone-turnover markers as well as markers of mineral metabolism could improve risk stratification. Emerging artificial intelligence-based modeling and HR-pQCT-guided phenotyping may enable individualized prevention strategies in kidney transplant recipients (KTRs).

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Untersulzner C, Pirklbauer M, Evenepoel P, et al. Bone Mineral Density Loss After Kidney Transplantation: Metabolic Determinants, Diagnostic Approaches, and Preventive Strategies. Kidney Int Rep. 2026. PMID: 42534417. doi:10.1016/j.ekir.2026.106685

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。